EPSTEIN-BARR VIRUS-RELATED LYMPHOMAGENESIS IN A CHILD WITH WISKOTT-ALDRICH SYNDROME

被引:8
作者
GULLEY, ML
CHEN, CL
RAABTRAUB, N
机构
[1] UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC
[2] UNIV N CAROLINA,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC
[3] UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599
[4] NATL TAIWAN UNIV,DEPT PATHOL,TAIPEI,TAIWAN
关键词
EPSTEIN-BARR VIRUS; WISKOTT-ALDRICH SYNDROME; LYMPHOMA; CD23; C-FGR;
D O I
10.1002/hon.2900110304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epstein-Barr virus (EBV) DNA was detected in immunoblastic lymphoma arising in a child with the primary immunodeficiency, Wiskott-Aldrich syndrome. Southern blot analysis of the structure of the EBV genome revealed that the lymphoma was monoclonal and contained episomal EBV DNA. The EBV latent genes, latent membrane protein 1 (LMP1) and the EBV nuclear antigen 2 (EBNA2), were detected by immunohistochemistry in the Wiskott-Aldrich lymphoma but not in an EBV-positive Burkitt's lymphoma, implying that host immune factors could influence EBV gene expression. Hybridization in situ demonstrated expression of EBV-encoded RNA (EBER), the cellular c-fgr protooncogene, and CD23 B-cell activation transcripts in the Wiskott-Aldrich lymphoma whereas EBER and c-fgr but not CD23 were expressed in the Burkitt's lymphoma. These data suggest that in primary immunodeficiency-related lymphoma, LMP1 and EBNA2 are expressed and that this expression correlates with expression of CD23. This supports previous in vitro studies showing that CD23 is specifically induced by LMP1 or EBNA2 genes. In contrast, expression of c-fgr may be independent of expression of these EBV latent genes.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 29 条
[1]   EXPRESSION OF DIFFERENTIATION AND ADHESION MOLECULES IN SPORADIC BURKITTS-LYMPHOMA [J].
AIELLO, A ;
DELIA, D ;
FONTANELLA, E ;
GIARDINI, R ;
RILKE, F ;
DELLAPORTA, G .
HEMATOLOGICAL ONCOLOGY, 1990, 8 (04) :229-238
[2]   ESTABLISHMENT AND CHARACTERIZATION OF 3 TRANSPLANTABLE EBV-CONTAINING NASOPHARYNGEAL CARCINOMAS [J].
BUSSON, P ;
GANEM, G ;
FLORES, P ;
MUGNERET, F ;
CLAUSSE, B ;
CAILLOU, B ;
BRAHAM, K ;
WAKASUGI, H ;
LIPINSKI, M ;
TURSZ, T .
INTERNATIONAL JOURNAL OF CANCER, 1988, 42 (04) :599-606
[3]  
FRIZZERA G, 1980, CANCER-AM CANCER SOC, V46, P692, DOI 10.1002/1097-0142(19800815)46:4<692::AID-CNCR2820460410>3.0.CO
[4]  
2-Q
[5]   DEMONSTRATION OF EPSTEIN-BARR-VIRUS IN IMMUNOBLASTIC SARCOMA OF B-CELLS ARISING IN A CHILD WITH PRIMARY IMMUNODEFICIENCY DISEASE [J].
GARTNER, JG ;
MURPHY, MN ;
DIOCEE, M ;
DESA, DJ ;
MCLAIN, KL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1987, 11 (09) :726-731
[6]   EPSTEIN-BARR-VIRUS SMALL NUCLEAR RNAS ARE NOT EXPRESSED IN PERMISSIVELY INFECTED-CELLS IN AIDS-ASSOCIATED LEUKOPLAKIA [J].
GILLIGAN, K ;
RAJADURAI, P ;
RESNICK, L ;
RAABTRAUB, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8790-8794
[7]  
GULLEY ML, 1992, CANCER, V70, P185, DOI 10.1002/1097-0142(19920701)70:1<185::AID-CNCR2820700129>3.0.CO
[8]  
2-J
[9]   EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN EXPRESSION IN HODGKIN AND REED-STERNBERG CELLS [J].
HERBST, H ;
DALLENBACH, F ;
HUMMEL, M ;
NIEDOBITEK, G ;
PILERI, S ;
MULLERLANTZSCH, N ;
STEIN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (11) :4766-4770
[10]   LATENT AND REPLICATING FORMS OF EPSTEIN-BARR VIRUS-DNA IN LYMPHOMAS AND LYMPHOPROLIFERATIVE DISEASES [J].
KATZ, BZ ;
RAABTRAUB, N ;
MILLER, G .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (04) :589-598